Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 338.08% | -49.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 338.08% | -49.81% | |||
| Cost of Revenue | 431.40% | -27.98% | |||
| Gross Profit | 256.83% | -60.29% | |||
| SG&A Expenses | 17.45% | -4.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 180.72% | 4.95% | |||
| Operating Income | -160.53% | -8.98% | |||
| Income Before Tax | -111.49% | -11.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -111.49% | -11.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -111.49% | -11.41% | |||
| EBIT | -160.53% | -8.98% | |||
| EBITDA | -166.12% | -9.37% | |||
| EPS Basic | -111.19% | -11.37% | |||
| Normalized Basic EPS | -154.01% | -7.75% | |||
| EPS Diluted | -322.93% | -11.37% | |||
| Normalized Diluted EPS | -154.01% | -7.75% | |||
| Average Basic Shares Outstanding | 0.16% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||